Skip to content

The Effects of Two Different Orthosis on Pain, Hand Strength and Function in Patients With Thumb Carpometacarpal Osteoarthritis

The Effects of Hand Orthosis in Thumb Osteoarthritis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03327480
Enrollment
60
Registered
2017-10-31
Start date
2018-01-01
Completion date
2018-11-01
Last updated
2017-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis Thumb

Keywords

osteoarthritis thumb, orthosis, functioning

Brief summary

The investigators aimed to assess the effects of two different hand orthosis on hand functioning, pain, disability and quality of life in patients with thumb osteoarthritis

Detailed description

The investigators will randomized 60 patients with stage 1 or 2 thumb osteoarthritis in two groups. The investigators will prescribe a neoprene CMC orthosis for patients in Group 1 and a thermoplastic CMC orthosis for patients in Group 2. The investigators will recommend these orthosis for six weeks. They will assess pain and disability before and after the treatment.

Interventions

Group 1: neoprebe CMC orthosis Group2: thermoplastic CMC orthosis

Sponsors

Diskapi Teaching and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled prospective trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Being aged between 18 and 70 * Grade 1 or 2 thumb osteoarthritis

Exclusion criteria

* The other hand disorders such as fracture and carpal tunnel syndrome * Previous hand surgery

Design outcomes

Primary

MeasureTime frameDescription
AUSCAN (Australian Canadian Oateoarthritis Hand Index)before the treatment, end of the sixth weekThis scale is used to assess of pain, disability and stiffness. Change is being assesed. Total score is ranged between 0-90.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026